Dicerna Pharmaceuticals Snags Deal With Japan's Kyowa Hakko to Develop RNAi Cancer Treatments; Dicerna Will Get $4 Million Upfront, $120 Million in Milestone Payments
1/4/2010 7:35:44 AM
More...
|
Kyowa Hakko: Brain Imaging Study Confirms Cognizin(R) Citicoline Boosts Mental Function
6/8/2009 10:52:19 AM
More...
|
Sanofi-Aventis (France) (SASY.PA) Signs $315 Million Deal with Kyowa Hakko
5/20/2009 6:26:56 PM
More...
|
Arana Therapeutics and Kyowa Hakko to Co-develop Anti-cancer Drug; Agreement Worth Up to $8M
4/24/2008 8:03:49 AM
More...
|
Amgen (AMGN) Buys Licensing Rights from Kyowa Hakko; Amgen to Pay $100M Upfront
3/6/2008 7:07:08 AM
More...
|
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
2/28/2008 7:50:13 AM
More...
|
ArQule, Inc. (ARQL) Receives $3 Million Milestone from Kyowa Hakko
2/6/2008 8:45:30 AM
More...
|
Kyowa Hakko Nine-Month Operating Income Up 20.6%; Raises Full-year Forecasts
1/30/2008 9:22:28 AM
More...
|
Kyowa Hakko Interim Operating Income up 25.2%
10/29/2007 11:52:50 AM
More...
|
Kyowa Hakko Release: Submission of New Drug Application for Istradefylline(KW-6002), an Investigational Anti-Parkinson's Disease Drug
4/27/2007 11:42:11 AM
More...
|
|